Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 848 participants.

Also called NCT06530537

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 848 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06530537
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06530537. Randomized; no masking; primary purpose treatment. Start 2024-07-18 (actual); primary completion 2031-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cilostazol vs. Aspirin in Acute Non-cardioembolic Stroke With Cerebral mIcrobleeds
Condition
Cerebral Microbleeds
Condition
Stroke
Intervention (Drug)
Cilostazol
Intervention (Drug)
Aspirin
Lead sponsor
Zhejiang Provincial People's Hospital (class: other)

Record details

Record id
cardio:ct-nct06530537
Content hash
24264dd42a9f27b86a790e4fb709d3fed22a3f7cb25dc38c91d45976716cef54